Ophthalmology Times Europe E-News:
Having trouble viewing this e-mail? Click here. 		You are subscribed to %%list.name%% as %%emailaddr%%.
Unsubscribe from this list.
Ophthalmology Times Europe E-News
Modern Medicine Network
 
 
 
 
TOP SEARCHES: OCT // Canaloplasty // AMD
In this issue
• Retinal cell death
• Brachytherapy system
• Stem Cells
• Surgical platform
• Surgery study
Survey

DO you primarily perform LASIK or PRK procedures?
Novartis

LASIK

64%

PRK

21%

Neither

14%


You can now follow us on Twitter:
www.twitter.com/oteurope

Contact Us
Click here to contact Pamela Brook, editor.

Click here to contact Neil Hanley, sales manager.
 
NOVEMBER 25, 2009
Protecting retinal cells could save sight
A study into the process of retinal cell death could hold the key to stopping a variety of eye diseases that cause blindness, according to a report from a team of researchers from the Yale School of Medicine reported in the journal Investigative Ophthalmology & Visual Science. More...
First neovascular AMD patients in Europe treated with epimacular brachytherapy system
NeoVista has announced that treatment for neovascular AMD using the company’s VIDON ANV Therapy System has begun in Europe. The new system replaces the current course of eye injections with a surgical vitrectomy and a single dose of beta radiation. More...
Treating eye disease with stem cells
Advanced Cell Technology has filed an Investigational New Drug (IND) application with the US Food and Drug Administration (FDA) to initiate a Phase I/II multicenter study using embryonic-stem-cell-derived retinal cells to treat patients with Stargardt’s Macular Dystrophy (SMD). More...
CE mark awarded
Oertli’s new surgical platform Faros, has received its CE mark after meeting EU consumer safety, health or environmental requirements. This important step for the platform keeps it on schedule for an expected March 2010 release. More...
Errors in the OR
Poor communication is leading to a high number of mistakes in ophthalmic surgeries, according to a study published in the November issue of Archives of Surgery. More...
The ExciStar XS series from Coherent, Inc. represents a compact, economical excimer laser offering performance and lifetime characteristics. The air cooled ExciStar XS measures 0,08 m3, yet delivers pulse energies up to 12mJ at 248nm with an energy stability of <2% (1σ), at repetition rates of 500 Hz. The use of Almeta XS tube design and all solid state pulser results in a product lifetime that lasts for more than 1 billion pulses. Read more...

You are subscribed to %%list.name%% as %%emailaddr%%. To unsubscribe from this list click here.

To ensure delivery to your Inbox, please add %%email.list%% to your address book. If you need help doing this, click here.

Advanstar Communications provides certain customer contact data (such as customers' names, addresses, phone numbers and e-mail addresses) to third parties who wish to promote relevant products, services and other opportunities which may be of interest to you. If you do not want Advanstar Communications to make your contact information available to third parties for marketing purposes, please contact us by emailing [email protected] or by mail at Advanstar Communications, Advanstar House, Park West, Sealand Road, Chester, CH1 4RN, UK.